SinfatinOrganisationDevelopsRimonabanteuclinicaltrials.euTrialsEvaluation of the Safety and Efficacy of Rimonabant on Cognitive impairment in patients with post-COVID-19 Syndrome.Phase 2, Not yet recruiting, 80 people, 28 Sept 2026, euclinicaltrials.eu